Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy

by lowes1 on October 16, 2013

Condition:   NSCLC
Intervention:   Drug: Icotinib
Sponsors:   Anhui Medical University;   Anhui Medical University
Not yet recruiting – verified October 2013

View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days

Leave a Comment

Previous post:

Next post: